BACKGROUND AIMS: Adipose tissue represents a practical source of autologous mesenchymal stromal cells (MSCs) and vascular-endothelial progenitor cells, available for regenerative therapy without in vitro expansion. One of the problems confronting the therapeutic application of such cells is how to immobilize them at the wound site. We evaluated in vitro the growth and differentiation of human adipose stromal vascular fraction (SVF) cells after delivery through the use of a fibrin spray system. METHODS: SVF cells were harvested from four human adult patients undergoing elective abdominoplasty, through the use of the LipiVage system. After collagenase digestion, mesenchymal and endothelial progenitor cells (pericytes, supra-adventitial stromal cells, endothelial progenitors) were quantified by flow cytometry before culture. SVF cells were applied to culture vessels by means of the Tisseel fibrin spray system. SVF cell growth and differentiation were documented by immunofluorescence staining and photomicrography. RESULTS: SVF cells remained viable after application and were expanded up to 3 weeks, when they reached confluence and adipogenic differentiation. Under angiogenic conditions, SVF cells formed endothelial (vWF+, CD31+ and CD34+) tubules surrounded by CD146+ and α-smooth muscle actin+ perivascular/stromal cells. CONCLUSIONS: Human adipose tissue is a rich source of autologous stem cells, which are readily available for regenerative applications such as wound healing, without in vitro expansion. Our results indicate that mesenchymal and endothelial progenitor cells, prepared in a closed system from unpassaged lipoaspirate samples, retain their growth and differentiation capacity when applied and immobilized on a substrate using a clinically approved fibrin sealant spray system.
BACKGROUND AIMS: Adipose tissue represents a practical source of autologous mesenchymal stromal cells (MSCs) and vascular-endothelial progenitor cells, available for regenerative therapy without in vitro expansion. One of the problems confronting the therapeutic application of such cells is how to immobilize them at the wound site. We evaluated in vitro the growth and differentiation of human adipose stromal vascular fraction (SVF) cells after delivery through the use of a fibrin spray system. METHODS: SVF cells were harvested from four human adult patients undergoing elective abdominoplasty, through the use of the LipiVage system. After collagenase digestion, mesenchymal and endothelial progenitor cells (pericytes, supra-adventitial stromal cells, endothelial progenitors) were quantified by flow cytometry before culture. SVF cells were applied to culture vessels by means of the Tisseel fibrin spray system. SVF cell growth and differentiation were documented by immunofluorescence staining and photomicrography. RESULTS: SVF cells remained viable after application and were expanded up to 3 weeks, when they reached confluence and adipogenic differentiation. Under angiogenic conditions, SVF cells formed endothelial (vWF+, CD31+ and CD34+) tubules surrounded by CD146+ and α-smooth muscle actin+ perivascular/stromal cells. CONCLUSIONS:Human adipose tissue is a rich source of autologous stem cells, which are readily available for regenerative applications such as wound healing, without in vitro expansion. Our results indicate that mesenchymal and endothelial progenitor cells, prepared in a closed system from unpassaged lipoaspirate samples, retain their growth and differentiation capacity when applied and immobilized on a substrate using a clinically approved fibrin sealant spray system.
Authors: M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz Journal: Cytotherapy Date: 2006 Impact factor: 5.414
Authors: Ludovic Zimmerlin; Albert D Donnenberg; J Peter Rubin; Per Basse; Rodney J Landreneau; Vera S Donnenberg Journal: Tissue Eng Part A Date: 2010-09-17 Impact factor: 3.845
Authors: Han Li; Ludovic Zimmerlin; Kacey G Marra; Vera S Donnenberg; Albert D Donnenberg; J Peter Rubin Journal: Plast Reconstr Surg Date: 2011-09 Impact factor: 4.730
Authors: A M Müller; A Mehrkens; D J Schäfer; C Jaquiery; S Güven; M Lehmicke; R Martinetti; I Farhadi; M Jakob; A Scherberich; I Martin Journal: Eur Cell Mater Date: 2010-03-03 Impact factor: 3.942
Authors: Ludovic Zimmerlin; Vera S Donnenberg; Melanie E Pfeifer; E Michael Meyer; Bruno Péault; J Peter Rubin; Albert D Donnenberg Journal: Cytometry A Date: 2010-01 Impact factor: 4.355
Authors: Shyam S Chaurasia; Ravi Champakalakshmi; Romesh I Angunawela; Donald T Tan; Jodhbir S Mehta Journal: Transl Vis Sci Technol Date: 2012-06-29 Impact factor: 3.283
Authors: Alexander J Whittam; Zeshaan N Maan; Dominik Duscher; Victor W Wong; Janos A Barrera; Michael Januszyk; Geoffrey C Gurtner Journal: Adv Wound Care (New Rochelle) Date: 2016-02-01 Impact factor: 4.730
Authors: Joanne Li; Yair Pincu; Marina Marjanovic; Andrew J Bower; Eric J Chaney; Tor Jensen; Marni D Boppart; Stephen A Boppart Journal: J Biomed Opt Date: 2016-08-01 Impact factor: 3.170
Authors: Ludovic Zimmerlin; Tea Soon Park; Elias T Zambidis; Vera S Donnenberg; Albert D Donnenberg Journal: Biochimie Date: 2013-06-05 Impact factor: 4.079
Authors: Anja Lena Thiebes; Manuel Armin Reddemann; Johannes Palmer; Reinhold Kneer; Stefan Jockenhoevel; Christian Gabriel Cornelissen Journal: Tissue Eng Part C Methods Date: 2016-03-18 Impact factor: 3.056
Authors: Riccardo Schweizer; Matthias Waldner; Sinan Oksuz; Wensheng Zhang; Chiaki Komatsu; Jan A Plock; Vijay S Gorantla; Mario G Solari; Lauren Kokai; Kacey G Marra; J Peter Rubin Journal: Front Immunol Date: 2020-05-06 Impact factor: 7.561
Authors: Anja Lena Thiebes; Stefanie Albers; Christian Klopsch; Stefan Jockenhoevel; Christian G Cornelissen Journal: Biores Open Access Date: 2015-06-01
Authors: Ursula Hopfner; Matthias M Aitzetmueller; Philipp Neßbach; Michael S Hu; Hans-Guenther Machens; Zeshaan N Maan; Dominik Duscher Journal: Stem Cells Int Date: 2018-12-19 Impact factor: 5.443